Clinical Trial

"Hepatic Substrate Flux Rates in Type 2 Diabetes"

Study acronym: IMPACT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Investigation of the effects of redox shuttle inhibition by metformin on gluconeogenic flux rates of lactate and glycerol in humans with type 2 diabetes
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-09-12; most recent amendment 2025-01-09.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-01-09
Status change: Recruiting → Enrolling by Invitation 2023-06-10
Trial Details
NCT Number NCT04088851
Lead Sponsor German Diabetes Center
Collaborators: Yale University
Conditions Type 2 Diabetes
Enrollment 23 participants
Start Date 2019-09-11
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-13